National Cancer Centre, Singapore
Clinical trials sponsored by National Cancer Centre, Singapore, explained in plain language.
-
New drug hope for rare throat and thyroid cancers
Disease control Not yet recruitingThis study tests a drug called sacituzumab tirumotecan in 68 people whose adenoid cystic carcinoma (a rare salivary gland cancer) or papillary thyroid cancer has returned or spread. The drug is given by IV twice a month. The main goal is to see if tumors shrink. This is not a cur…
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Acupuncture needles vs. chemo brain: new study tests a surprising fix
Symptom relief Not yet recruitingThis study tests whether 10 sessions of electroacupuncture (a type of acupuncture with mild electric pulses) can improve memory, focus, and thinking in cancer survivors who struggle with 'chemo brain.' Researchers will compare real acupuncture to a sham (fake) version and a waitl…
Phase: PHASE3 • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Sniff away symptoms: aromatherapy trial targets dementia distress
Symptom relief Not yet recruitingThis study tests whether daily exposure to a blend of essential oils can improve mood and behavior in people with mild cognitive impairment or early dementia, and also reduce stress for their caregivers. About 200 patients and their caregivers will try aromatherapy at home for at…
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
Lifestyle tweaks may cut liver cancer risk, new study hints
Knowledge-focused Not yet recruitingThis study looks at whether lifestyle changes can reduce the risk of liver cancer in people already at high risk. Researchers will track changes in bile acids, gut bacteria, and liver health in 90 adults aged 50 to 90. The goal is to see if these adjustments can lower the chances…
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Knowledge-focused
Last updated May 26, 2026 05:06 UTC